Opus Genetics, Inc.
IRD
$4.94
-$0.25-4.82%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 5.33% | -135.23% | 9.45% | 76.68% | -366.85% |
| Total Depreciation and Amortization | 0.00% | -7.14% | 7.69% | 30.00% | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -36.55% | 19,025.45% | 89.40% | -101.98% | 3,277.51% |
| Change in Net Operating Assets | -91.66% | 131.16% | -855.10% | -120.85% | -12.86% |
| Cash from Operations | -59.70% | 40.04% | -14.18% | -20.92% | -44.99% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -100.00% | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 364.27% | -- | -100.00% | -- | -100.00% |
| Repurchase of Common Stock | -- | -- | 100.00% | 2.70% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 85.92% | -640.43% | -100.67% | 30,767.39% | 55.34% |
| Cash from Financing | 430.68% | 401.43% | -95.57% | 24,756.63% | -123.51% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 984.51% | 82.76% | -181.62% | 281.76% | -32.11% |